CHRISTALYN WILLIAMS: Open Payments
NPI 1811425135 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,363 in 118 payments from 33 companies in 2025. Trend: 2023 $1,523 · 2024 $1,603 · 2025 $2,363
Food & beverage: $2,363
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $430 |
| Janssen Biotech, Inc. | 18 | $329 |
| Regeneron Healthcare Solutions, Inc. | 8 | $162 |
| Merck Sharp & Dohme LLC | 7 | $147 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $127 |
| Genentech USA, Inc. | 6 | $111 |
| Incyte Corporation | 5 | $107 |
| BeOne Medicines USA, Inc. | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
Products named: KISQALI, Nubeqa, LIBTAYO, KEYTRUDA, LUTATHERA, REBLOZYL, TALVEY, ERLEADA.
Industry payments across AL — which companies pay providers there.
